Learn from experts at the forefront of Parkinson’s Research
The COVID-19 pandemic was an impetus for industry-wide digital endpoint validation already underway in Parkinson’s research. Learn from two experts at the forefront of this research, Josh Cosman PhD , Director of Digital Health Strategy at AbbVie, and David Anderson PhD, Senior Scientist at Clinical ink, as they discuss the patient experience. They will address why digital transformation is well-positioned in this therapeutic area, and how validating WATCH-PD decentralized study design, BrainBaselineTM technology, and digital endpoints serve as a harbinger for Parkinson’s and movement disorders research, as well as clinical discovery at large.
This webinar is a dynamic conversation revealing challenges in traditional study models, the power of expertly engineered technologies, data capture, and analytic methods, and opportunities for growth direct from patients, sponsors, sites, and the broader Parkinson’s research community.